Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for QSI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 180.20M
March 31, 2026 200.74M
December 31, 2025 220.23M
September 30, 2025 235.16M
June 30, 2025 220.98M
March 31, 2025 246.92M
December 31, 2024 215.42M
September 30, 2024 210.52M
June 30, 2024 233.26M
March 31, 2024 253.77M
December 31, 2023 271.62M
September 30, 2023 292.06M
June 30, 2023 315.30M
Date Value
March 31, 2023 339.00M
December 31, 2022 358.71M
September 30, 2022 387.45M
June 30, 2022 413.50M
March 31, 2022 441.88M
December 31, 2021 477.03M
September 30, 2021 493.92M
June 30, 2021 503.94M
March 31, 2021 97.08M
December 31, 2020 36.09M
September 30, 2020 112.23M
June 30, 2020 0.024M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Champions Oncology, Inc. 3.939M
Medpace Holdings, Inc. 433.86M
Avantor, Inc. 5.630B
Personalis, Inc. 235.16M
Adaptive Biotechnologies Corp. 142.91M

Shareholders Equity (Quarterly) Related Metrics